BioNTech SE (BNTX) to Hold Digital Press Conference on December 8, 2021 at 9AM ET to Provide an Update on Omicron Variant

Pfizer (PFE) and BioNtech (BNTX) Announces Study Shows Omicron Variant is Neutralized by Their COVID-19 Vaccine With Three Doses

December 8, 2021 6:55 AM EST

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq:... More

Pfizer (PFE), BioNTech SE (BNTX) Say Three Vaccine Doses Neutralize Omicron Variant - DJ

December 8, 2021 6:48 AM EST

(Updated - December 8, 2021 6:53 AM EST)

Pfizer (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) said a third dose of their vaccine neutralized Omicron in lab tests, according to Dow Jones.

The two-dose regimen was significantly less... More

Studies suggest Pfizer shot may protect only partially against Omicron

December 7, 2021 4:11 PM EST

(Raises paragraphs on global alarms)

By Michael Erman and Ludwig Burger

(Reuters) - The Omicron variant can partially evade protection from two doses of Pfizer and partner BioNTech's COVID-19 vaccine, the research head of a laboratory at the Africa Health Research Institute in South Africa said on Tuesday.

But the study showed that blood from people who had received two doses of the vaccine and had a prior infection was mostly able to neutralize the variant, suggesting that booster doses of the vaccine could help to fend off infection.

The Omicron variant, first detected in... More

Moderna (MRNA), BioNTech (BNTX) Trade to High as Study Show Reduced Protection of Current Vaccine vs Omicron

December 7, 2021 3:30 PM EST

Moderna (NASDAQ: MRNA), BioNTech SE (NASDAQ: BNTX) Trade to High as Study Show Reduced Protection of Current Vaccine vs Omicron

... More

Study Shows 40-Fold Reduction in Neutralization Capacity of Pfizer (PFE) Vaccines Vs Omicron - DJ

December 7, 2021 3:21 PM EST

Study Shows 40-Fold Reduction in Neutralization Capacity of Pfizer (NYSE: PFE) Vaccines Vs Omicron - DJ

... More

Africa Health's Sigal: Omicron Pfizer Immune Escape Incomplete - Bloomberg

December 7, 2021 3:14 PM EST

Africa Health's Sigal: Omicron Pfizer Immune Escape Incomplete - Bloomberg

... More

U.S. boosters surge to all-time high on Omicron fears

December 7, 2021 1:37 PM EST

By Ahmed Aboulenein and Michael Erman

WASHINGTON (Reuters) - Americans are lining up for booster doses of COVID-19 vaccines at a record pace, with concerns about the newly-detected Omicron coronavirus variant spurring millions to get shots, the U.S. government said on Tuesday.

Just under a million people a day received booster doses of one of the three authorized vaccines last week, the highest rate since U.S. regulators gave the nod to additional shots for some adults in September, government data shows.

"In the last week, we've gotten nearly 7 million people a booster; that's a... More

South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - exec

December 6, 2021 8:58 AM EST

KIGALI (Reuters) -South Africa's Biovac Institute will start making Pfizer-BioNTech's COVID-19 vaccine early next year after receiving the drug substance from Europe, a Pfizer executive said on Monday.

Biovac's "fill and finish" deal with Pfizer, announced in July, will make it one of the few companies processing COVID-19 shots in Africa, where many countries have struggled to access sufficient doses during the pandemic.

"We expect that the Cape Town facility will be incorporated into our supply chain... More

BioNTech (BNTX) PT Raised to $349 at BofA Securities

December 6, 2021 6:14 AM EST

BofA Securities analyst Tazeen Ahmad raised the price target on BioNTech (NASDAQ: BNTX) to $349.00 (from $341.00) while maintaining a Neutral rating.... More